Basic Degree in Biology (FCUL, 1982)
PhD in Cell Physiology (IGC e UNL, 1987)
Agregação in Neurosciences (FMUL, 2002).
Researcher at Gulbenkian Science Institute de 1987 a 1997
Professor at FMUL since 1997 (Full Professor since 2013)
Professor of Pharmacology and Neuroscience, Faculty of Medicine, University of Lisbon (start 2009)
Sub-Dean of the Faculty of Medicine (2016 - June 2022)
Director of the Institute for Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon (beginning 2011)
Director of the Research Unit of the Institute of Molecular Medicine (beginning 2007)
Member of the Scientific Council of the Faculty of Medicine, University of Lisbon (beginning 2013)
Director of the PhD Program in Integrative Neurosciences (funded by FCT) (start 2015)
Director of the Mind-Brain College of the University of Lisbon (2015-2018)
Member of the Scientific Council of the Master and PhD Programs in Neurosciences, Faculty of Medicine, University of Lisbon (Start 2007)
Member of the Scientific Council of the Master's and PhD Programs in Cognitive Sciences, University of Lisbon (Beginning 2008)
Member of the Coordinating Council of the Integrated Master's Degree Course in Biomedical Engineering, University of Lisbon (Start 2007)
Member of the Editorial Board of the Journal of Neurochemistry (beginning 2001)
Member of the Editorial Board of European Journal of Pharmacology
Member of the editorial board of Purinergic Signalling
Member of the National Academy of Medicine of Portugal (Full member since 2011)
Member of the Executive Committee of EPHAR (2002-2008)
Former Member of the School Council of the Faculty of Medicine of the University of Lisbon (end of 2016)
Past-Coordinator of GAPIC, a council of the School of Medicine dedicated to the creation of incentives for scientific research by medical students (2006-2009)
President of the Portuguese Society for Neuroscience (President 2003-2007)
President of the Portuguese Society of Pharmacology (President 2000-2003)
Research Area
Neuropharmacology
Control mechanisms of synaptic activity and neuronal excitability
Neuromodulation by adenosine, caffeine, neurotrophic factors, cannabinoids and other psychoactive substances
Implications for the control of nervous system dysfunctions such as epilepsy and neurodegenerative diseases (animal models).
